Soleno Therapeutics Inc
CFO
2026-03-02–present
Jennifer Fulk
CFO
Soleno Therapeutics Inc
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jennifer Fulk
Jennifer Fulk is recorded as CFO at Soleno Therapeutics Inc. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Jennifer Fulk resigned as Chief Financial Officer, effective May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed February 26, 2026 that Jennifer Fulk was appointed Chief Financial Officer, effective March 2, 2026.
“each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer of the Company, in each case, effective as of the Effective Time.”
“On its earnings call on February 25, 2026, Soleno Therapeutics, Inc. (the "Company") announced the appointment of Jennifer Fulk as the Company's Chief Financial Officer, effective upon her first day of employment, which is expected to be March 2, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Soleno Therapeutics Inc
CFO
SEC 8-K
Current2026-03-02–present
-
Soleno Therapeutics Inc
CFO
SEC 8-K
2026-03-02–2026-05-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.